top of page
< Back

Latanoprost

拉坦前列素

Mechanism of action:

Latanoprost 是一種前列腺素 F₂α 類衍生物(prostaglandin F₂α analog)。Latanoprost 為前驅藥,經角膜吸收後,在眼內被酯酶水解為活性型 latanoprost acid。活性型 latanoprost acid 會結合於睫狀肌與鞏膜上的前列腺素 F 受體(prostaglandin F receptor),啟動下游訊號傳遞。透過誘導基質金屬蛋白酶(matrix metalloproteinase)表達,改變睫狀肌細胞外基質結構,使房水更容易經由葡萄膜-鞏膜途徑排出眼外,從而有效降低眼內壓。

​Reference(s):

1. Hara T et al. (2001). Increased iris pigmentation after use of latanoprost in Japanese brown eyes. Nippon Ganka Gakkai Zasshi. 


2. Patel SS et al. (1996). Latanoprost: a review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging. 


3. Alm A et al. (2014). Latanoprost in the treatment of glaucoma. Clin Ophthalmol.

bottom of page